Search results
Results from the Tech24 Deals Content Network
The magazine was founded in 1994 by Sean Strub, an HIV-positive and openly gay businessman and activist. Before launching POZ, Strub was involved with numerous social issues, including politics, environmentalism, civil rights, LGBT rights, and HIV/AIDS. He is now executive director of the Sero Project, which focuses on ending inappropriate ...
An estimated 0.7% [0.6-0.8%] of adults aged 15–49 years worldwide are living with HIV, although the burden of the epidemic continues to vary considerably between countries and regions. The WHO African Region remains most severely affected, with nearly 1 in every 25 adults (3.4%) living with HIV and accounting for more than two-thirds of the ...
February 20, 2024. (2024-02-20) (aged 39) Las Vegas, Nevada, U.S. Known for. HIV/AIDS activism. Hydeia Loren Broadbent (June 14, 1984 – February 20, 2024) was an American HIV/AIDS activist who advocated through appearances in national media and as a spokesperson for related foundations. Born with HIV, Broadbent began taking part in trials for ...
The International Community of Women Living with HIV/AIDS (ICW), a registered UK charity, [ 1] is an international network run for and by HIV positive women. ICW was established to support programs designed to safeguard and improve the quality of life for women living with HIV. ICW Global [ 2] operates in 120 countries through ten regional ...
Jennifer Jako (born February 14, 1973) [1] is an AIDS activist, filmmaker, photographer, lecturer and designer.She is the co-director of the documentary film, Blood Lines, a portrait of HIV-positive youth.
For premium support please call: 800-290-4726 more ways to reach us
The Global Network of People living with HIV ( GNP+) is an international network representing all people living with HIV and AIDS. Their main agenda covers sexual and reproductive health/rights, human rights and the empowerment of people living with HIV and is named by GNP+ as the "Global Advocacy Agenda". This agenda was agreed upon at the ...
The twice-yearly injection of the drug lenacapavir can provide total protection against HIV infections, demonstrating 100% efficacy in Phase 3 trial data released by drugmaker Gilead and published ...